000 01468 a2200409 4500
005 20250517134012.0
264 0 _c20171024
008 201710s 0 0 eng d
022 _a1531-7048
024 7 _a10.1097/MOH.0000000000000328
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDulmovits, Brian M
245 0 0 _aCharacterization, regulation, and targeting of erythroid progenitors in normal and disordered human erythropoiesis.
_h[electronic resource]
260 _bCurrent opinion in hematology
_cMay 2017
300 _a159-166 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnemia
_xdrug therapy
650 0 4 _aAnimals
650 0 4 _aBiomarkers
650 0 4 _aCell Differentiation
_xdrug effects
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCell Self Renewal
_xdrug effects
650 0 4 _aErythroid Precursor Cells
_xcytology
650 0 4 _aErythropoiesis
_xdrug effects
650 0 4 _aGlucocorticoids
_xpharmacology
650 0 4 _aHumans
650 0 4 _aImmunologic Factors
_xpharmacology
650 0 4 _aImmunophenotyping
650 0 4 _aPhenotype
650 0 4 _aThalidomide
_xanalogs & derivatives
700 1 _aHom, Jimmy
700 1 _aNarla, Anupama
700 1 _aMohandas, Narla
700 1 _aBlanc, Lionel
773 0 _tCurrent opinion in hematology
_gvol. 24
_gno. 3
_gp. 159-166
856 4 0 _uhttps://doi.org/10.1097/MOH.0000000000000328
_zAvailable from publisher's website
999 _c26795806
_d26795806